Autolus Therapeutics plc ADR (AUTL) Stock Could Soon Reward Patient Investors

Autolus Therapeutics plc ADR (NASDAQ: AUTL) is -45.50% lower on its value in year-to-date trading and has touched a low of $3.06 and a high of $7.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AUTL stock was last observed hovering at around $3.73 in the last trading session, with the day’s loss setting it -0.22%.

Currently trading at $3.51, the stock is -14.30% and -11.79% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.6 million and changing -5.90% at the moment leaves the stock -23.16% off its SMA200. AUTL registered 0.57% gain for a year compared to 6-month gain of -12.47%. The firm has a 50-day simple moving average (SMA 50) of $3.9875 and a 200-day simple moving average (SMA200) of $4.5798.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -15.22% loss in the last 1 month and extending the period to 3 months gives it a -6.40%, and is 5.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.23% over the week and 8.01% over the month.

Autolus Therapeutics plc ADR (AUTL) has around 463 employees, a market worth around $933.84M and $10.50M in sales. Profit margin for the company is -2229.04%. Distance from 52-week low is 14.71% and -52.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.80%).

with sales reaching $130k over the same period.The EPS is expected to grow by 31.58% this year, but quarterly earnings will post 798.70% year-over-year. Quarterly sales are estimated to shrink -68.00% in year-over-year returns.

Autolus Therapeutics plc ADR (AUTL) Top Institutional Holders

The shares outstanding are 266.05M, and float is at 236.60M with Short Float at 3.70%.

The top institutional shareholder in the company is SYNCONA PORTFOLIO LTD with over 21.35 million shares valued at $74.29 million. The investor’s holdings represent 9.6083% of the AUTL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKSTONE INC. with 20.49 million shares valued at $71.29 million to account for 9.2207 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 17.89 million shares representing 8.0523% and valued at over $62.26 million, while DEEP TRACK CAPITAL, LP holds 6.8741 of the shares totaling 15.27 million with a market value of $53.15 million.